Research on European Children and Adults born Preterm (RECAP preterm)
Background: from data collection to data sharing
The overall aim of the EU-funded research project RECAP preterm is to improve health, development, and quality of life of children and adults born very preterm (VP) or with a very low birth weight (VLBW):
- VP: less than 32 weeks of gestation
- VLBW: less than 1500 g
The innovative element of RECAP preterm is to provide the bridge from data collection to data sharing: the members aim to establish a digital platform for harmonising and exploiting data of European cohort studies with babies, children, and adults born preterm as well as Nordic registry data. This broadened data basis shall ensure improved understanding, diagnosis and evidence-based, personalised prevention of mental and somatic disorders that are associated with preterm birth. Long term effects of different treatments, especially the use of (off-label) medication applied for these patients are meant to be analysed by combining adult cohorts with available data from preterm babies. By developing mHealth applications, the cohort participants shall be encouraged to sustainably collect follow-up data (mHealth/mobile health = the use of information and
communication technology for collecting health data, delivery of healthcare information, monitoring of patient vital signs, and telemedicine).
RECAP preterm will…
- create a sustainable data platform of national and European cohorts of VP/VLBW children and adults to optimise the use of population data for research and innovation in healthcare and policy (view more)
- develop hypothesis-driven research on health status and medical care of VP/VLBW children and adults that builds on the unique opportunities provided by the larger sample sizes of combined cohorts and the added value of their geographic and temporal diversity
- integrate exchange with various stakeholders to disseminate results and to translate them into evidence-based care and policy (e.g. obstetricians, neonatologists, paediatricians, psychologists, psychiatrists, other healthcare providers, educators, scientists, economists, policy planners, health insurance companies, and patient and parent groups).
- emphasise patient and public involvement in order to reflect real-world needs.
Members and Partners
The RECAP preterm consortium
RECAP preterm brings together European child to adult cohorts and a group of highly experienced organisations. The expertise of the partners covers a wide and complementary range of fields, including life course epidemiology, methodology, neonatology, paediatrics, early-life stressors, non-communicable disease research, epigenomics, economics, psychology, and mental health as well as e-learning technologies, eHealth/mHealth applications, communication, dissemination and project management.
View more about the different participating institutions
Milestones by EFCNI
- EFCNI’s role in RECAP preterm lies particularly in leading all activities regarding dialogue, dissemination, and sustainability by reaching out to the scientific community, clinicians, healthcare professionals, patient organisations, the general public, policy makers, and other potential stakeholders at the national, European, and international level to increase the visibility as well as the health and societal impact of RECAP preterm. A particular focus will be placed on parents in the interaction and dissemination strategy in particular to identify and answer user-driven research questions and policy needs.
- By organising a workshop on “Translation of Research into Policy” EFCNI and all RECAP partners will reach out to the European policy level.
- We will also support our project partners to conduct a summer school with clinicians and researchers to promote the RECAP preterm platform and to train them on the evidence generated by the project.
Next steps for 2017
- Start stakeholder mapping process
- Verbalise the upcoming research findings in order that they are easier to understand for non-expert target groups like the general public or parents and patients
Links and Downloads
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 733280.